Condition: Ischemia Reperfusion Injury · Cardiac Surgery Associated - Acute Kidney Injury · Sponsor: Bilix Co.,Ltd.
This is a Randomized, Single-blind, Multi-center, Placebo-controlled, Phase 2a clinical trial of BX-001N to prevent patients from Cardiac Surgery Associated Acute Kidney Injury (CSA-AKI) and subsequent Major Adverse Kidney Events (MAKE) in approximately 50 participants.
This description comes directly from the study's public registry record.
Choonmo Kang · +82-70-7791-5721 · choonmo.kang@bilix.com
Soobin Son · +82-31-212-0961 · Soobin.Son@bilix.com
Always discuss trial participation with your own doctor first.
| Keimyung University Dongsan Medical Center | Daegu, South Korea | Not Yet Recruiting |
| Seoul National University Bundang Hospital | Seongnam, South Korea | Not Yet Recruiting |
| Korea University Anam Hospital | Seoul, South Korea | Recruiting |
| Seoul National University Hospital | Seoul, South Korea | Recruiting |
| Severance Hospital | Seoul, South Korea | Recruiting |
| Seoul Asan Medical center | Seoul, South Korea | Recruiting |
| Samsung Medical Center | Seoul, South Korea | Not Yet Recruiting |
| Pusan National University Yangsan Hospital | Yangsan, South Korea | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07164833